a few months after the genetic test maker filed for bankruptcy. Labcorp expects this transaction would generate approximately $275 million-$300 million in annual revenue, with the majority in ...
Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for ...
Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests. Labcorp is paying $192.5 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback